Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Regazzi

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Clinical Pharmacokinetics|May 1, 1997
Clinical pharmacokinetics of tretinoinM B Regazzi, I Iacona, C Gervasutti, et al.
Il Farmaco; Edizione Pratica|June 1, 1988
[Evaluation of possible significant pharmacokinetic interactions between butizide and potassium canrenoate in man]M B Regazzi, F Farinelli, G Corsico, et al.
Journal of Clinical Pharmacology|February 1, 1996
Pharmacokinetics of hydroxyurea in patients infected with human immunodeficiency virus type IP Villani, R Maserati, M B Regazzi, et al.
Scandinavian Journal of Infectious Diseases|August 26, 2000
Influenza immunization and indinavir pharmacokineticsR Maserati, P Villani, G Barasolo, et al.
Arzneimittel-Forschung|April 1, 1991
Pharmacokinetics of omeprazole in cirrhotic patientsM Rinetti, M B Regazzi, P Villani, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Cefoxitin in newborn infants. A clinical and pharmacokinetic studyM B Regazzi, G Chirico, D Cristiani, et al.
British Journal of Haematology|August 1, 1995
Modulation of all-trans retinoid acid pharmacokinetics in acute promyelocytic leukaemia by prolonged interferon-alpha therapyM Lazzarino, A Corso, M B Regazzi, et al.
Journal of the National Cancer Institute|October 16, 1996
Response of aleukemic granulocytic sarcoma to all-trans-retinoic acid plus interferon alfa-2aS Toma, R Palumbo, D Giordano, et al.
Minerva Medica|March 31, 1985
[Bioavailability of a delayed-action aminophylline preparation]M B Regazzi, E Guarnone, A Bartoli, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
The effect of aging on the pharmacokinetics of nizatidineP Villani, M B Regazzi, M Pecorini, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Clinical Pharmacokinetics|May 1, 1997
Clinical pharmacokinetics of tretinoinM B Regazzi, I Iacona, C Gervasutti, et al.
Il Farmaco; Edizione Pratica|June 1, 1988
[Evaluation of possible significant pharmacokinetic interactions between butizide and potassium canrenoate in man]M B Regazzi, F Farinelli, G Corsico, et al.
Journal of Clinical Pharmacology|February 1, 1996
Pharmacokinetics of hydroxyurea in patients infected with human immunodeficiency virus type IP Villani, R Maserati, M B Regazzi, et al.
Scandinavian Journal of Infectious Diseases|August 26, 2000
Influenza immunization and indinavir pharmacokineticsR Maserati, P Villani, G Barasolo, et al.
Arzneimittel-Forschung|April 1, 1991
Pharmacokinetics of omeprazole in cirrhotic patientsM Rinetti, M B Regazzi, P Villani, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Cefoxitin in newborn infants. A clinical and pharmacokinetic studyM B Regazzi, G Chirico, D Cristiani, et al.
British Journal of Haematology|August 1, 1995
Modulation of all-trans retinoid acid pharmacokinetics in acute promyelocytic leukaemia by prolonged interferon-alpha therapyM Lazzarino, A Corso, M B Regazzi, et al.
Journal of the National Cancer Institute|October 16, 1996
Response of aleukemic granulocytic sarcoma to all-trans-retinoic acid plus interferon alfa-2aS Toma, R Palumbo, D Giordano, et al.
Minerva Medica|March 31, 1985
[Bioavailability of a delayed-action aminophylline preparation]M B Regazzi, E Guarnone, A Bartoli, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
The effect of aging on the pharmacokinetics of nizatidineP Villani, M B Regazzi, M Pecorini, et al.
Pageof 8